Amyloid-β peptide protects against microbial infection in mouse and worm models of Alzheimer's disease.
Level 5 - mechanism / opinion, no new human data
Preclinical in vitro and animal models (mice, nematodes, cell culture) with no human clinical data.
PubMed 27225182 · doi:10.1126/scitranslmed.aaf1059
What was done
Researchers evaluated the antimicrobial properties and mechanisms of amyloid-β (Aβ) expression and oligomerization against bacterial and fungal pathogens across cell culture, nematode, and transgenic mouse (5XFAD) models of Alzheimer's disease. They examined the binding of Aβ oligomers to microbial cell wall carbohydrates, protofibril formation, and the effects of intracerebral Salmonella Typhimurium infection on β-amyloid deposition in mice.
What was found
The abstract reports qualitative findings without numerical metrics or effect sizes. Aβ expression protected against bacterial and fungal infections across mouse, nematode, and cell culture models. Soluble Aβ oligomers bound microbial cell wall carbohydrates via a heparin-binding domain, protofibrils inhibited pathogen adhesion to host cells, and propagating fibrils mediated agglutination and entrapment of unattached microbes. Intracerebral S. Typhimurium infection in 5XFAD mice resulted in rapid seeding and accelerated β-amyloid deposition directly colocalizing with invading bacteria.
Why it matters
This study provides evidence that amyloid-β may act as an antimicrobial peptide within innate immunity, suggesting that infectious or sterile inflammatory stimuli could drive amyloid deposition in Alzheimer's disease.
Limits
The study is entirely preclinical, relying on cell culture, nematode, and mouse models, without human clinical data. The abstract reports no numerical values, effect sizes, or sample sizes (n = ?). Whether microbial infection triggers typical sporadic human Alzheimer's disease remains unestablished.
Cited by
- supports Rudy Tanzi's research demonstrated that microbes, viruses, and bacteria from the microbiome are present in brain biopsies of Alzheimer's patients, triggering amyloid plaque deposition as an immune response.
- supports Amyloid aggregates have been shown in laboratory studies to create holes in bacterial cell membranes, leading to the hypothesis that amyloid functions as an antibacterial protein.